SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : AXCAN Pharma(AXCA)..A GUT FEELING! -- Ignore unavailable to you. Want to Upgrade?


To: Arthur Radley who wrote (22)9/4/2000 1:49:07 PM
From: Arthur Radley  Respond to of 46
 
Chase H&Q issued a Daily Notes Report on August 7, 2000 for Axcan Pharma.
On August 7, 2000 Chase H&Q analyst Alex Zisson issued a 5 page Daily Notes Report on Axcan Pharma. Report highlights: 'The company announced an agreement to develop and supply Diomed's laser as the light source for Photofrin. A BUY rating was reiterated based on the increased potential as a result of the agreement. Earnings growth of 60% should be generated over the next three years.'